Profile | GDS2987 / GI_18087850-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 18.7 | 53 |
GSM215244 | HMVEC_vehicle_rep2 | 22.5 | 49 |
GSM215253 | HMVEC_vehicle_rep3 | 10.5 | 34 |
GSM215254 | HMVEC_atorvastatin_rep1 | 32.7 | 61 |
GSM215282 | HMVEC_atorvastatin_rep3 | 17.7 | 38 |
GSM215344 | HMVEC_atorvastatin_rep2 | 31.9 | 59 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 22.8 | 41 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 22.3 | 41 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 55.5 | 64 |
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | 31.2 | 52 |
GSM215296 | HMVEC_SLx2119_rep3 | 30.2 | 45 |
GSM215297 | PASMC_vehicle_rep1 | 58.6 | 63 |
GSM215298 | PASMC_vehicle_rep2 | 45.3 | 56 |
GSM215310 | PASMC_vehicle_rep3 | 18.8 | 30 |
GSM215311 | PASMC_atorvastatin_rep1 | 40.1 | 56 |
GSM215312 | PASMC_atorvastatin_rep2 | 37.6 | 51 |
GSM215313 | PASMC_atorvastatin_rep3 | 23.5 | 34 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 54.1 | 63 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 50.4 | 64 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 21 | 34 |
GSM215327 | PASMC_SLx2119_rep1 | 36.1 | 53 |
GSM215328 | PASMC_SLx2119_rep2 | 25.5 | 42 |
GSM215329 | PASMC_SLx2119_rep3 | 22.4 | 40 |
GSM215330 | Fibroblasts_vehicle_rep1 | 37.8 | 61 |
GSM215331 | Fibroblasts_vehicle_rep2 | 22.4 | 51 |
GSM215332 | Fibroblasts_vehicle_rep3 | 27.8 | 61 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 42.3 | 66 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 19.4 | 47 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 26.8 | 53 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 9 | 29 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | ||
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 23 | 53 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 23.3 | 54 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 28 | 58 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 12 | 30 |